Oncodesign Company

Oncodesign develops anticancer therapies for the treatment of patients with cancer.

Founded Date: 1995-01-01
Technology: Precision Medicine
Investor Type: For Profit
Funding Status: IPO
Total Funding: $29.4M
Employee Number: 101-250
Headquarters: Others
Investors Number: 3
Last Funding Type: Venture - Series Unknown
Estimated Revenue: $1M to $10M
Industry: P4 Medicine